Kambayashi Yumi 神林由美

Researcher Number	50755303
Other IDs
Affiliation (Current)	2025: 東北大学, 大学病院, 助教
Affiliation (based on the past Project Information) *help	2023: 東北大学, 大学病院, 助教 2020 – 2022: 東北大学, 医学系研究科, 助教 2017 – 2018: 東北大学, 医学系研究科, 助教 2016: 東北大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 53050:Dermatology-related / Dermatology Except Principal Investigator Dermatology
Keywords	Principal Investigator 悪性黒色腫 / メラノーマ / M2マクロファージ / 腫瘍随伴性マクロファージ / ケモカイン / 免疫療法 / PAI-I阻害薬 / 抗PD-1抗体 / 抗PD-1抗体治療効果 / 腫瘍内浸潤リンパ球 … More / ヒト血管内皮細胞３次元培養 / MMP-9 / 血管新生 / PAI-1 / 炎症性サイトカイン / 芳香族炭化水素受容体（AhR） / 腫瘍随伴性マクロファージ（TAMｓ） / 血管新生因子 / 局所浸潤 / IL-17 / 発芽型血管新生 / 重複型血管新生 / IL-23p19 / MMP9 / MMP1 / LL37 / 腫瘍免疫 / アポクリン系腫瘍 / 免疫寛容 / RANKL/RANK / アポクリン腺癌 / 乳房外パジェット病 / RANKL … More Except Principal Investigator PD-1/ PD-L1 / 抑制型免疫環境 / ケモカイン / 腫瘍随伴マクロファージ / 腫瘍免疫 / 免疫関連副作用 / 治療 / 治療効果予測メカニズム / 免疫チェックポイント阻害薬 / 免疫調整因子 / sCD163 / 皮膚悪性腫瘍 / 腫瘍随伴性マクロファージ / 免疫療法 / 悪性黒色腫 Less

PAI-1・免疫チェックポイント相互阻害による新規免疫療法の開発Principal Investigator
- Principal Investigator
  
  神林由美
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Tohoku University
LL37 might promote local invasion of melanoma by the stimulation of melanoma cells and tumor-associated macrophagesPrincipal Investigator
- Principal Investigator
  
  Kambayashi Yumi
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Tohoku University
Development of novel immune therapy for melanoma by targeting tumor associated macrophages
- Principal Investigator
  
  Fujimura Taku
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Dermatology
- Research Institution
  Tohoku University
Possible mechanisms of induction of immunotolerance in appocrine-origin skin tumorsPrincipal Investigator
- Principal Investigator
  
  Kambayashi Yumi
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Dermatology
- Research Institution
  Tohoku University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016

All Journal Article Presentation

[Journal Article] Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides2024
- Author(s)
  Fujimura Taku、Ohuchi Kentaro、Ikawa Tetsuya、Kambayashi Yumi、Amagai Ryo、Furudate Sadanori、Asano Yoshihide
- Journal Title
  
  Hematological Oncology
  
  Volume: 42 Issue: 1
- DOI
  10.1002/hon.3244
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K19525, KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K16275
[Journal Article] Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab2023
- Author(s)
  Amagai Ryo、Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Yamazaki Emi、Hashimoto Akira、Asano Yoshihide
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 16 Issue: 1 Pages: 1490-1493
- DOI
  10.1159/000534657
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-21K08318
[Journal Article] Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas.2023
- Author(s)
  Ohuchi K, Amagai R, Ikawa T, Muto Y, Roh Y, Endo J, Maekawa T, Kambayashi Y, Asano Y, Fujimura T.
- Journal Title
  
  Experimental Dermatology
  
  Volume: 32 Issue: 1 Pages: 50-59
- DOI
  10.1111/exd.14681
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399
[Journal Article] LL-37 might promote local invasion of melanoma by activating melanoma cells and tumor-associated macrophages.2023
- Author(s)
  2.Ohuchi K, Ikawa T, Amagai R,Takahashi T, Roh Y, Endo J, Kambayashi Y, Asano Y, Fujimura T.
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 6 Pages: 1678-1678
- DOI
  10.3390/cancers15061678
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-23K19525
[Journal Article] CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas2023
- Author(s)
  Yamamoto Jun、Ohuchi Kentaro、Amagai Ryo、Roh Yuna、Endo Junko、Chiba Hiromu、Tamabuchi Erika、Kambayashi Yumi、Hashimoto Akira、Asano Yoshihide、Fujimura Taku
- Journal Title
  
  Skin Health and Disease
  
  Volume: 3 Issue: 3
- DOI
  10.1002/ski2.222
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K19525, KAKENHI-PROJECT-22K08399
[Journal Article] Adverse events associated with postoperative outcomes of adjuvant <scp>anti‐PD</scp>‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study2023
- Author(s)
  Muto Yusuke、Kambayashi Yumi、Kato Hiroshi、Fukushima Satoshi、Ito Takamichi、Maekawa Takeo、Fujisawa Yasuhiro、Yoshino Koji、Uchi Hiroshi、Matsushita Shigeto、Yamamoto Yuki、Amagai Ryo、Ohuchi Kentaro、Hashimoto Akira、Asano Yoshihide、Fujimura Taku
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 51 Issue: 3 Pages: 458-462
- DOI
  10.1111/1346-8138.16912
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-21K08351
[Journal Article] Efficacy and safety of <scp>TM5614</scp> in combination with paclitaxel in the treatment of paclitaxel‐resistant cutaneous angiosarcoma: Phase <scp>II</scp> study protocol2023
- Author(s)
  Fujimura Taku、Yoshino Koji、Nakamura Motoki、Kato Hiroshi、Ito Takamichi、Maekawa Takeo、Fujisawa Yasuhiro、Matsushita Shigeto、Amagai Ryo、Yamazaki Emi、Takahashi Manami、Tamabuchi Erika、Hashimoto Akira、Kambayashi Yumi、Yamazaki Naoya、Miyata Toshio、Asano Yoshihide
- Journal Title
  
  Experimental Dermatology
  
  Volume: 33 Issue: 1
- DOI
  10.1111/exd.14976
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-21K08318
[Journal Article] Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy2022
- Author(s)
  Yamamoto Haruka、Kambayashi Yumi、Tamabuchi Erika、Hashimoto Akira、Asano Yoshihide、Fujimura Taku
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 35 Issue: 11
- DOI
  10.1111/dth.15850
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08399
[Journal Article] Cutaneous T-cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real-world case series.2022
- Author(s)
  Amagai R, Kambayashi Y, Ohuchi K, Furudate S, Hashimoto A, Asano Y, Fujimura T.
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 35 Issue: 11
- DOI
  10.1111/dth.15858
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399, KAKENHI-PROJECT-22K16275
[Journal Article] Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy2022
- Author(s)
  Kambayashi Yumi、Ohuchi Kentaro、Chiba Hiromu、Tamabuchi Erika、Nagasawa Tasuku、Asano Yoshihide、Fujimura Taku
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 15 Issue: 2 Pages: 469-472
- DOI
  10.1159/000524013
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08399
[Journal Article] Serum CCL22 increased in advanced melanoma patients with liver metastase: report of 5 cases.2022
- Author(s)
  Ohuchi K, Amagai R, Kambayashi Y, Asano Y, Fujimura T.
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 15 Issue: 3 Pages: 1114-1120
- DOI
  10.1159/000528328
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399
[Journal Article] Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy2022
- Author(s)
  Ohuchi Kentaro、Amagai Ryo、Tamabuchi Erika、Kambayashi Yumi、Fujimura Taku
- Journal Title
  
  The Journal of Dermatology
  
  Volume: - Issue: 5
- DOI
  10.1111/1346-8138.16304
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17337, KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399
[Journal Article] Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.2022
- Author(s)
  Kambayashi Y, Kasahara Y, Ohuchi K, Amagai R, Hashimoto A, Asano Y, Fujimura T.
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 35 Issue: 10
- DOI
  10.1111/dth.15736
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K08318, KAKENHI-PROJECT-22K08399
[Journal Article] Successful treatment of BRAF/MEK inhibitor‐resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity‐modulated radiotherapy2021
- Author(s)
  Okuma Takami、Furudate Sadanori、Kambayashi Yumi、Hashimoto Akira、Aiba Setsuya、Fujimura Taku
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 48 Issue: 9 Pages: 1419-1422
- DOI
  10.1111/1346-8138.15962
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337, KAKENHI-PROJECT-21K08318
[Journal Article] Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma2021
- Author(s)
  Muto Yusuke、Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Amagai Ryo、Okuma Takami、Furudate Sadanori、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 48 Issue: 3
- DOI
  10.1111/1346-8138.15747
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case report2021
- Author(s)
  Amagai Mayuko、Ozawa Maki、Amagai Ryo、Ohuchi Kentaro、Muto Yusuke、Kambayashi Yumi、Aiba Setsuya、Fujimura Taku
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 35 Issue: 3
- DOI
  10.1111/dth.15290
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337, KAKENHI-PROJECT-21K08318
[Journal Article] Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas2021
- Author(s)
  Fujimura Taku、Amagai Ryo、Kambayashi Yumi、Aiba Setsuya
- Journal Title
  
  Pharmaceutics
  
  Volume: 13 Issue: 2 Pages: 200-200
- DOI
  10.3390/pharmaceutics13020200
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Successful treatment of CCR4 + mycosis fungoides palmaris et plantaris with mogamulizumab monotherapy2020
- Author(s)
  Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Amagai Ryo、Muto Yusuke、Aiba Setsuya
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 33 Issue: 4
- DOI
  10.1111/dth.13731
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment2020
- Author(s)
  Ohuchi Kentaro、Fujimura Taku、Kambayashi Yumi、Amagai Ryo、Lyu Chunbing、Tanita Kayo、Sato Yota、Aiba Setsuya
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 33 Issue: 4
- DOI
  10.1111/dth.13487
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical Investigation2020
- Author(s)
  Yoshida Saaya、Fujimura Taku、Ohuchi Kentaro、Kambayashi Yumi、Segawa Yuichiro、Yamazaki Emi、Tono Hisayuki、Takahashi Toshiya、Tsuchiyama Kenichiro、Aiba Setsuya
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 13 Issue: 1 Pages: 462-467
- DOI
  10.1159/000506975
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Successful treatment of unresectable recurrent cutaneous squamous cell carcinoma of the scalp with meningeal invasion with nivolumab monotherapy2020
- Author(s)
  Fujimura Taku、Kambayashi Yumi、Tono Hisayuki、Lyu Chinbing、Ohuchi Kentaro、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 33 Issue: 4
- DOI
  10.1111/dth.13672
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used2020
- Author(s)
  Ogata Dai、、、Kambayashi Yumi、Yoshikawa Syusuke、Yamazaki Naoya、Tsuchida Tetsuya
- Journal Title
  
  European Journal of Cancer
  
  Volume: 127 Pages: 108-117
- DOI
  10.1016/j.ejca.2019.12.018
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock2020
- Author(s)
  Muto Yusuke、Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Amagai Ryo、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 13 Issue: 3 Pages: 1141-1144
- DOI
  10.1159/000510261
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapy2020
- Author(s)
  Fujimura Taku、Sato Yota、Tanita Kayo、Amagai Ryo、Shimauchi Takatoshi、Ogata Dai、Fukushima Satoshi、Miyashita Azusa、Fujisawa Yasuhiro、Kambayashi Yumi、Aiba Setsuya
- Journal Title
  
  The Journal of Dermatology
  
  Volume: - Issue: 6 Pages: 636-640
- DOI
  10.1111/1346-8138.15322
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16345, KAKENHI-PROJECT-20K17337, KAKENHI-PROJECT-18K08301
[Journal Article] Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma2020
- Author(s)
  Amagai Ryo、Fujimura Taku、Muto Yusuke、Kambayashi Yumi、Furudate Sadanori、Ohuchi Kentaro、Okuma Takami、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 34 Issue: 1
- DOI
  10.1111/dth.14544
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy2020
- Author(s)
  Kambayashi Yumi、Fujimura Taku、Kuroda Hiroshi、Otsuka Atsushi、Irie Hiroyuki、Aiba Setsuya
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 13 Issue: 1 Pages: 474-477
- DOI
  10.1159/000506976
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study2020
- Author(s)
  Fujisawa Y.、Fujimura T.、Matsushita S.、Yamamoto Y.、Uchi H.、Otsuka A.、Funakoshi T.、Miyagi T.、Hata H.、Gosho M.、Kambayashi Y.、Aoki M.、Yanagi T.、Ohira A.、Nakamura Y.、Maeda T.、Yoshino K.
- Journal Title
  
  British Journal of Dermatology
  
  Volume: 183 Issue: 5 Pages: 831-839
- DOI
  10.1111/bjd.19042
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Treatment of Advanced Melanoma: Past, Present and Future2020
- Author(s)
  Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Muto Yusuke、Aiba Setsuya
- Journal Title
  
  Life
  
  Volume: 10 Issue: 9 Pages: 208-208
- DOI
  10.3390/life10090208
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Immune checkpoint inhibitor‐induced vitiligo in advanced melanoma could be related to increased levels of CCL192020
- Author(s)
  Fujimura T.、Tanita K.、Sato Y.、Lyu C.、Kambayashi Y.、Fujisawa Y.、Uchi H.、Yamamoto Y.、Otsuka A.、Yoshino K.、Matsushita S.、Funakoshi T.、Fukushima S.、Hata H.、Hashimoto A.、Aiba S.
- Journal Title
  
  British Journal of Dermatology
  
  Volume: 182 Issue: 5 Pages: 1297-1300
- DOI
  10.1111/bjd.18721
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Case series of BRAF ‐mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy2020
- Author(s)
  Fujimura Taku、Yoshino Koji、Kato Hiroshi、Fujisawa Yasuhiro、Nakamura Yoshiyuki、Yamamoto Yuki、Kunimoto Kayo、Ito Takamichi、Matsushita Shigeto、Maekawa Takeo、Ohuchi Kentaro、Amagai Ryo、Muto Yusuke、Furudate Sadanori、Kambayashi Yumi、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 48 Issue: 3 Pages: 397-400
- DOI
  10.1111/1346-8138.15688
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanoma2020
- Author(s)
  Fujimura Taku、Tanita Kayo、Ohuchi Kentaro、Sato Yota、Lyu Chunbing、Kambayashi Yumi、Fujisawa Yasuhiro、Tanaka Ryota、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Melanoma Research
  
  Volume: 30 Issue: 6 Pages: 613-618
- DOI
  10.1097/cmr.0000000000000685
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Severe pyrexia from nivolumab‐resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinib2020
- Author(s)
  Amagai Ryo、Fujimura Taku、Kambayashi Yumi、Sato Yota、Tanita Kayo、Ohuchi Kentaro、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 47 Issue: 6 Pages: 654-657
- DOI
  10.1111/1346-8138.15346
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy2020
- Author(s)
  Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Amagai Ryo、Sato Yota、Tanita Kayo、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 13 Issue: 1 Pages: 271-275
- DOI
  10.1159/000506327
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapy2020
- Author(s)
  Muto Yusuke、Fujimura Taku、Kambayashi Yumi、Ohuchi Kentaro、Amagai Ryo、Okuma Takami、Furudate Sadanori、Hashimoto Akira、Aiba Setsuya
- Journal Title
  
  Dermatologic Therapy
  
  Volume: 33 Issue: 6
- DOI
  10.1111/dth.14430
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17337
[Journal Article] First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements2019
- Author(s)
  Okabe T, Fujimura T, Okajima J, Kambayashi Y, Aiba S, Maruyama S.
- Journal Title
  
  Sci Rep
  
  Volume: 9 Issue: 1 Pages: 1-7
- DOI
  10.1038/s41598-019-40444-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H04273, KAKENHI-PROJECT-16K10143, KAKENHI-PROJECT-17K14599
[Journal Article] Successful control of phototherapy-resistant lymphomatoid papulosis with oral bexarotene.2018
- Author(s)
  Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.
- Journal Title
  
  Journal of Dermatology
  
  Volume: 45 Issue: 2
- DOI
  10.1111/1346-8138.14095
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.2018
- Author(s)
  Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S.
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 11 Issue: 1 Pages: 114-118
- DOI
  10.1159/000487127
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143, KAKENHI-PROJECT-16K19703
[Journal Article] Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy.2018
- Author(s)
  Fujimura T, Tanita K, Sato Y, Kambayashi Y, Furudate S, Tsukada A, Hashimoto A, Aiba S.
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 11 Issue: 1 Pages: 29-32
- DOI
  10.1159/000486278
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab.2018
- Author(s)
  Fujimura T, Kambayashi Y, Hidaka T, Tamabuchi E, Otake E, Tono H, Mizuashi M, Furudate S, Aiba S.
- Journal Title
  
  Journal of Dermatology
  
  Volume: 45 Issue: 2
- DOI
  10.1111/1346-8138.14085
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod.2018
- Author(s)
  Fujimura T, Kambayashi Y, Sato Y, Tanita K, Furudate S, Tsukada A, Tono H, Hashimoto A, Aiba S.
- Journal Title
  
  Case Reports in Oncology
  
  Volume: 11 Issue: 1 Pages: 1-5
- DOI
  10.1159/000485612
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.2018
- Author(s)
  Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.
- Journal Title
  
  Anticancer Res.
  
  Volume: 38 Pages: 113-120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19703
[Journal Article] Tumor-associated macrophages: Therapeutic targets for skin cancer.2018
- Author(s)
  Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S.
- Journal Title
  
  Frontier in Oncology
  
  Volume: 8 Pages: 3-3
- DOI
  10.3389/fonc.2018.00003
- NAID
  120007134526
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143, KAKENHI-PROJECT-16K19703
[Journal Article] Two cases of Vogt-Koyanagi Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/ trametinib therapy.2018
- Author(s)
  Fujimura T, Kambayashi Y, Tanita K, Sato Y, Hidaka T, Otsuka A, Tanaka H, Furudate S, Hashimoto A, Aiba S.
- Journal Title
  
  Journal of Dermatology
  
  Volume: 印刷中 Issue: 6 Pages: 735-737
- DOI
  10.1111/1346-8138.14273
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy.2018
- Author(s)
  Sato Y, Fujimura T, Kambayashi Y, Hashimoto A, Aiba S.
- Journal Title
  
  Case Rep Oncol
  
  Volume: 11 Issue: 1 Pages: 212-215
- DOI
  10.1159/000488236
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19703
[Journal Article] The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.2018
- Author(s)
  Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.
- Journal Title
  
  Anticancer Res.
  
  Volume: 38 Pages: 113-120
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.2018
- Author(s)
  Fujimura T, Kakizaki A, Kambayashi Y, Sato Y, Tanita K, Lyu C, Furudate S, Aiba S.
- Journal Title
  
  Experimental Dermatology
  
  Volume: 27 Issue: 1 Pages: 64-70
- DOI
  10.1111/exd.13417
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143, KAKENHI-PROJECT-16K19703
[Journal Article] BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials2018
- Author(s)
  Fujimura T, Hidaka T, Kambayashi Y, Aiba S
- Journal Title
  
  Expert Opin Investig Drugs
  
  Volume: 28 Issue: 2 Pages: 143-148
- DOI
  10.1080/13543784.2019.1558442
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H04273, KAKENHI-PROJECT-16K10143
[Journal Article] The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.2018
- Author(s)
  Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.
- Journal Title
  
  Anticancer Reserch
  
  Volume: 38 Pages: 113-120
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.2018
- Author(s)
  Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.
- Journal Title
  
  Oncotarget.
  
  Volume: 9 Issue: 21 Pages: 15542-15551
- DOI
  10.18632/oncotarget.24509
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19703, KAKENHI-PROJECT-16K10143
[Journal Article] Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma2018
- Author(s)
  Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S.
- Journal Title
  
  Front Oncol
  
  Volume: 19 Pages: 530-530
- DOI
  10.3389/fonc.2018.00530
- NAID
  120007133653
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H04273, KAKENHI-PROJECT-16K10143
[Journal Article] Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity-modulated radiotherapy.2018
- Author(s)
  Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.
- Journal Title
  
  Journal of Dermatology
  
  Volume: 印刷中 Issue: 4
- DOI
  10.1111/1346-8138.14111
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma2018
- Author(s)
  Fujimura T, Sato Y, Kambayashi Y, Tanita K, Tsukada A, Terui H, Hashimoto A, Aiba S.
- Journal Title
  
  Br J Dermatol
  
  Volume: 6 Issue: 6 Pages: 1392-1395
- DOI
  10.1111/bjd.16676
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H04273, KAKENHI-PROJECT-16K10143
[Journal Article] Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget’s disease by receptor activator of nuclear factor kappa-B ligand (RANKL)/ RANK pathways.2017
- Author(s)
  Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Takanori Hidaka, Setsuya Aiba.
- Journal Title
  
  British Journal of Dermatology
  
  Volume: 176 Issue: 2 Pages: 387-394
- DOI
  10.1111/bjd.14864
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143, KAKENHI-PROJECT-16K19703
[Journal Article] Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.2017
- Author(s)
  Furudate S, Fujimura T, Kambayashi Y, Hidaka T, Sato Y, Tanita K, Hashimoto A, Aiba S.
- Journal Title
  
  Journal of Dermatology
  
  Volume: 46 Issue: 9
- DOI
  10.1111/1346-8138.13898
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.2017
- Author(s)
  Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S.
- Journal Title
  
  Oncotarget
  
  Volume: 1 Pages: 1-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Phase I study of nivolumab combined with IFN-b for patients with advanced melanoma.2017
- Author(s)
  Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S.
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 41 Pages: 71177-71181
- DOI
  10.18632/oncotarget.17090
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Keratoacanthoma, palmoplantar keratoderma developing from an advanced melanoma patient treated with vemurafenib regressed by the blockade of MEK signaling.2017
- Author(s)
  3.Furudate S, Fujimura T, Kambayashi Y, Hidaka T, Sato Y, Tanita K, Hashimoto A, Aiba S
- Journal Title
  
  Journal of Dermatology
  
  Volume: 1 Pages: 1-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.2017
- Author(s)
  Furudate S, Fujimura T, Tsukada A, Sato Y, Hidaka T, Tanita K, Kambayashi Y, Haga T, Hashimoto A, Aiba S.
- Journal Title
  
  Case Rep Oncol
  
  Volume: 16 Issue: 1 Pages: 52-56
- DOI
  10.1159/000455091
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19703
[Journal Article] Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.2017
- Author(s)
  Furudate S, Fujimura T, Kambayashi Y, Kakizaki A, Hidaka T, Aiba S.
- Journal Title
  
  Anticancer Research
  
  Volume: 37 Pages: 3461-3471
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.2017
- Author(s)
  Fujimura T, Takahashi K, Kambayashi Y, Furudate S, Hidaka T, Kakizaki A, Watabe A, Haga T, Hashimoto A, Aiba S.
- Journal Title
  
  Anticancer Research
  
  Volume: 37 Pages: 1885-1889
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.2017
- Author(s)
  Furudate S, Fujimura T, Kambayashi Y, Kakizaki A, Hidaka T, Aiba S.
- Journal Title
  
  Anticancer Res
  
  Volume: 37 Pages: 3461-3471
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19703
[Journal Article] Phospho-STAT5B expression is a prognostic marker for Merkel cell carcinoma.2017
- Author(s)
  Fujimura T, Furudate S, Kambayashi Y, Kakizaki A, Yamamoto Y, Okuhira H, Fujimoto N, Aiba S.
- Journal Title
  
  Anticancer Research
  
  Volume: 1 Pages: 1-1
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Retrospective study of cutaneous squamous cell carcinoma on the lip treated with peplomycin administered through a superficial temporal artery.2017
- Author(s)
  Fujimura T, Takahashi K, Kambayashi Y, Furudate S, Hidaka T, Kakizaki A, Watabe A, Haga T, Hashimoto A, Aiba S.
- Journal Title
  
  Anticancer Research
  
  Volume: 1 Pages: 1-1
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K10143
[Journal Article] Tumor-associated macrophages in skin: how to treat their heterogeneity and plasticity.2016
- Author(s)
  Fujimura T, Kakizaki A, Furudate S, Kambayashi Y, Aiba S.
- Journal Title
  
  Journal of Dermatological Science
  
  Volume: 83 Issue: 3 Pages: 167-173
- DOI
  10.1016/j.jdermsci.2016.05.015
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461677, KAKENHI-PROJECT-16K10143
[Journal Article] RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ　from extramammary Paget disease.2016
- Author(s)
  藤村卓、神林由美、柿﨑彩、古舘禎騎、相場節也
- Journal Title
  
  Journal of Cutaneous Pathology
  
  Volume: 43 Issue: 9 Pages: 772-775
- DOI
  10.1111/cup.12743
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19703
[Journal Article] Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages.2016
- Author(s)
  藤村卓、神林由美、古舘禎騎、柿﨑彩、日高高徳、浅野雅之、相場節也
- Journal Title
  
  Experimental Dermatology
  
  Volume: 25 Issue: 5 Pages: 397-399
- DOI
  10.1111/exd.12949
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19703
[Presentation] 進行性悪性黒色腫治療におけるニボルマブ・PAI-1阻害薬併用療法の安全性・有効性の検討2023
- Author(s)
  進行性悪性黒色腫治療におけるニボルマブ・藤村卓, 吉野公二, 加藤裕史, 福島聡, 藤澤康弘, 石月翔一郎, 大塚篤司, 松下茂人, 神林由美, 浅野善英
- Organizer
  第39回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-22K08399
[Presentation] 骨髄癌腫症を呈した悪性黒色腫の1例　本邦報告例のまとめ2022
- Author(s)
  神林由美, 天貝諒, 大内謙太郎, 古舘禎騎, 高橋隼也, 橋本彰, 藤村卓, 市川聡
- Organizer
  第38回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-22K08399
[Presentation] Pro-angiogenic factors might predict the efficacy of bexarotene in advanced cutaneous T cell lymphomas.2022
- Author(s)
  Yumi Kambayashi, Taku Fujimura, Kentaro Ohuchi, Ryo Amagai, Yoshihide Asano
- Organizer
  The 47th Annual Meeting of the Japanese Society for Investigative Dermatology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08399
[Presentation] モガムリズマブ単剤療法無効例にエトポシド療法が著効した皮膚T細胞リンパ腫の3例2021
- Author(s)
  大内謙太郎, 藤村卓, 神林由美, 天貝諒, 佐藤遥太, 谷田佳世, 相場節也
- Organizer
  第36回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 進行期悪性黒色腫に対して免疫チェックポイント阻害剤投与により完全奏功を達成した後に休薬を行った4例2021
- Author(s)
  武藤雄介、藤村卓、神林由美、古舘禎騎、大内謙太郎、天貝諒、千葉広夢、大熊崇生、橋本彰、相場節也
- Organizer
  第37回日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 当科で使用した根治切除不能の悪性黒色腫に対するBRAF＋MEK阻害剤併用の使用経験2021
- Author(s)
  大熊崇生、藤村卓、神林由美、古舘禎騎、武藤雄介、大内謙太郎、天貝諒、千葉広夢、橋本彰、相場節也
- Organizer
  第37回日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] ゲノムパネルで新規治療のターゲットを発見した進行期悪性黒色腫の1例2021
- Author(s)
  神林由美, 藤村卓, 浅野雅之, 橋本彰, 相場節也, 城田英和
- Organizer
  第36回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 進行期悪性黒色腫における抗PD1抗体とのTM5614の安全性・有効性を検討する第II相試験2021
- Author(s)
  藤村卓、藤澤康弘、吉野公二、大塚篤司、松下茂人、神林由美、武藤雄介、大内謙太郎、橋本彰、相場節也
- Organizer
  第120回日本皮膚科学会総会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 根治切除不能悪性黒色腫における抗PD1抗体治療効果と従来予測因子との相関性の検証2021
- Author(s)
  藤村卓, 谷田佳世, 佐藤遥太, 神林由美, 藤澤康弘, 内博史, 山本有紀, 大塚篤司, 吉野公二, 相場節也
- Organizer
  第36回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 筋肉内転移をきたしたイマチニブで治療した隆起性皮膚線維肉腫の1例2021
- Author(s)
  神林由美、藤村卓、天貝諒、遠野久幸、相場節也、笠原佑記、綿貫宗則
- Organizer
  第37回日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 東北大学で経験したエンコラフェニブ、ビニメチニブ併用療法で加療した進行期悪性黒色腫の6例2020
- Author(s)
  大内謙太郎, 藤村卓, 天貝諒, 佐藤遥太, 谷田佳世, 玉渕恵里佳, 神林由美, 橋本彰, 相場節也
- Organizer
  第84回　　日本皮膚科学会東部支部学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] Encorafenib/Binimetinib併用療法によりスパイク熱を生じた3例　発症関連因子の検討2020
- Author(s)
  天貝諒, 藤村卓, 神林由美, 佐藤遥太, 大内謙太郎, 橋本彰, 相場節也
- Organizer
  第119回　日本皮膚科学会総会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] ベキサロテンにより治療した皮膚T細胞性リンパ腫　32例の多施設共同後ろ向き解析2020
- Author(s)
  佐藤遥太, 藤村卓, 神林由美, 緒方大, 島内隆寿, 藤澤康弘, 福島聡, 天貝諒, 谷田佳世, 相場節也
- Organizer
  第119回　日本皮膚科学会総会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 東北大学における進行期悪性黒色腫に対する抗PD-1抗体を用いた術後補助療法2020
- Author(s)
  天貝諒, 藤村卓, 神林由美, 大内謙太郎, 佐藤遥太, 谷田佳世, 遠野久幸, 橋本彰, 相場節也
- Organizer
  第36回　日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 抗PD1抗体治療に伴う白斑と治療効果の相関性の検証2020
- Author(s)
  藤村卓, 谷田佳世, 佐藤遥太, 神林由美, 藤澤康弘, 内博史, 山本有紀, 大塚篤司, 吉野公二, 相場節也
- Organizer
  第119回　日本皮膚科学会総会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] 東北大学におけるニボルマブ+イピリムマブ併用療法の使用経験2020
- Author(s)
  大内謙太郎, 藤村卓, 神林由美, 佐藤遥太, 谷田佳世, 天貝諒, 橋本彰, 相場節也
- Organizer
  第119回　日本皮膚科学会総会
- Data Source
  KAKENHI-PROJECT-20K17337
[Presentation] Lichen planus follicularis tumidusと鑑別を要した小児のmilia enplaqueの1例2018
- Author(s)
  神林由美
- Organizer
  日本皮膚科学会宮城地方会学術大会第３８１回例会・総会
- Data Source
  KAKENHI-PROJECT-16K19703
[Presentation] Safety dose and prediction of immune-related adverse event of nivolumab combined with IFN-beta in patients with advanced melanoma2017
- Author(s)
  Taku Fujimura, Yumi Kambayashi, Sadanori Furudate, Takanori Hidaka, Hisayuki Tono, Yota Sato, Kayo Tanita, Akira Hashimoto, Setsuya Aiba
- Organizer
  European Society for Dermatological Research 47th annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10143
[Presentation] ダブラフェニブ・トラメチニブ療法中に生じた多形紅斑重症型の1例2017
- Author(s)
  神林由美
- Organizer
  第69回日本皮膚科学会西部支部学術大会
- Data Source
  KAKENHI-PROJECT-16K19703
[Presentation] Phase I study of the nivolumab combined with IFN-beta in patients with advanced melanoma2017
- Author(s)
  Taku Fujimura, Yumi Kambayashi, Sadanori Furudate, Takanori Hidaka, Hisayuki Tono, Akira Tsukada, Akira Hashimoto, Setsuya Aiba
- Organizer
  Society for Investigative Dermatology 76 th annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10143
[Presentation] Bexarotene modulates the production of CCL22 from tumor-associated macrophages in patients with mycosis fungoides.2017
- Author(s)
  Kayo Tanita, Taku Fujimura, Yota Sato, Lyu Chunbing, Yumi Kambayashi, Sadanori Furudate, Setsuya Aiba
- Organizer
  Japanese Society for Investigative Dermatology　42th　annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10143
[Presentation] Immunomodulatory effects of classical chemotherapeutic agents for melanoma on M2macrophages2016
- Author(s)
  神林由美
- Organizer
  日本研究皮膚科学会
- Place of Presentation
  仙台国際センター(宮城県)
- Year and Date
  2016-12-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19703

1. Fujimura Taku (50396496)

# of Collaborated Projects: 1 results

# of Collaborated Products: 33 results
2. OKAJIMA Junnosuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. Kakizaki Aya

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 天貝諒

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
5. 円山重直

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. 岡部孝裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 宮下梓

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 相場節也

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kambayashi Yumi 神林 由美

Research Projects

Research Products

Co-Researchers

PAI-1・免疫チェックポイント相互阻害による新規免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

LL37 might promote local invasion of melanoma by the stimulation of melanoma cells and tumor-associated macrophagesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel immune therapy for melanoma by targeting tumor associated macrophages

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Possible mechanisms of induction of immunotolerance in appocrine-origin skin tumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] LL-37 might promote local invasion of melanoma by activating melanoma cells and tumor-associated macrophages.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Adverse events associated with postoperative outcomes of adjuvant <scp>anti‐PD</scp>‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and safety of <scp>TM5614</scp> in combination with paclitaxel in the treatment of paclitaxel‐resistant cutaneous angiosarcoma: Phase <scp>II</scp> study protocol2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cutaneous T-cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real-world case series.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum CCL22 increased in advanced melanoma patients with liver metastase: report of 5 cases.2022

Author(s)

Kambayashi Yumi 神林由美